Nektar Therapeutics Stock Price History

NKTR Stock  USD 0.85  0.01  1.26%   
Below is the normalized historical share price chart for Nektar Therapeutics extending back to May 03, 1994. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Nektar Therapeutics stands at 0.85, as last reported on the 30th of January, with the highest price reaching 0.86 and the lowest price hitting 0.82 during the day.
IPO Date
3rd of May 1994
200 Day MA
1.2571
50 Day MA
0.997
Beta
0.61
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Nektar Stock, it is important to understand the factors that can impact its price. Nektar Therapeutics has Sharpe Ratio of -0.12, which conveys that the firm had a -0.12 % return per unit of risk over the last 3 months. Nektar Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nektar Therapeutics' Mean Deviation of 3.17, risk adjusted performance of (0.13), and Standard Deviation of 4.3 to check out the risk estimate we provide.
  
At this time, Nektar Therapeutics' Common Stock Shares Outstanding is relatively stable compared to the past year. As of 01/30/2025, Liabilities And Stockholders Equity is likely to grow to about 707.3 M, while Common Stock Total Equity is likely to drop slightly above 16.2 K. . As of 01/30/2025, Price To Sales Ratio is likely to drop to 1.30. In addition to that, Price Earnings Ratio is likely to drop to -0.37. Nektar Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1206

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsNKTR

Estimated Market Risk

 4.33
  actual daily
38
62% of assets are more volatile

Expected Return

 -0.52
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.12
  actual daily
0
Most of other assets perform better
Based on monthly moving average Nektar Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nektar Therapeutics by adding Nektar Therapeutics to a well-diversified portfolio.
Price Book
3.1696
Enterprise Value Ebitda
(6.50)
Price Sales
1.6579
Shares Float
155 M
Wall Street Target Price
4.56

Nektar Therapeutics Stock Price History Chart

There are several ways to analyze Nektar Stock price data. The simplest method is using a basic Nektar candlestick price chart, which shows Nektar Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 5, 20241.4
Lowest PriceJanuary 28, 20250.84

Nektar Therapeutics January 30, 2025 Stock Price Synopsis

Various analyses of Nektar Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Nektar Stock. It can be used to describe the percentage change in the price of Nektar Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Nektar Stock.
Nektar Therapeutics Price Rate Of Daily Change 1.01 
Nektar Therapeutics Price Action Indicator 0.02 
Nektar Therapeutics Accumulation Distribution 46,523 
Nektar Therapeutics Price Daily Balance Of Power 0.27 

Nektar Therapeutics January 30, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Nektar Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Nektar Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Nektar Stock and then apply it to test your longer-term investment strategies against Nektar.

Nektar Stock Price History Data

The price series of Nektar Therapeutics for the period between Fri, Nov 1, 2024 and Thu, Jan 30, 2025 has a statistical range of 0.57 with a coefficient of variation of 15.48. The daily prices for the period are spread out with arithmetic mean of 1.08. The median price for the last 90 days is 1.02. The company underwent 2:1 stock split on 23rd of August 2000.
OpenHighLowCloseVolume
01/30/2025 0.84  0.86  0.82  0.85  1,000,242 
01/29/2025 0.82  0.87  0.80  0.84  1,663,296 
01/28/2025 0.87  0.88  0.84  0.84  1,108,055 
01/27/2025 0.89  0.92  0.86  0.88  1,342,978 
01/24/2025 0.89  0.90  0.87  0.88  1,498,409 
01/23/2025 0.92  0.93  0.89  0.89  1,282,227 
01/22/2025 0.92  0.96  0.89  0.92  767,035 
01/21/2025 0.91  0.94  0.84  0.90  844,135 
01/17/2025 0.89  0.94  0.88  0.89  1,792,837 
01/16/2025 0.90  0.93  0.88  0.89  1,103,766 
01/15/2025 0.93  0.96  0.90  0.91  1,341,825 
01/14/2025 0.99  0.99  0.87  0.90  1,111,712 
01/13/2025 1.01  1.01  0.93  0.96  1,801,891 
01/10/2025 1.10  1.12  1.02  1.03  1,650,697 
01/08/2025 1.23  1.24  1.12  1.14  1,843,848 
01/07/2025 1.17  1.25  1.14  1.19  2,525,696 
01/06/2025 1.15  1.22  1.13  1.17  2,656,173 
01/03/2025 0.96  1.16  0.96  1.10  2,795,303 
01/02/2025 0.96  1.02  0.93  0.96  909,106 
12/31/2024 0.92  0.96  0.91  0.93  1,113,207 
12/30/2024 0.93  0.96  0.93  0.94  704,857 
12/27/2024 0.91  0.96  0.90  0.95  1,098,147 
12/26/2024 0.92  0.96  0.88  0.95  1,090,573 
12/24/2024 0.89  0.91  0.89  0.91  505,654 
12/23/2024 0.93  0.93  0.87  0.90  1,711,305 
12/20/2024 0.96  0.96  0.90  0.93  1,787,433 
12/19/2024 0.92  1.00  0.89  0.94  1,639,350 
12/18/2024 1.02  1.04  0.92  0.93  1,515,937 
12/17/2024 1.00  1.03  1.00  1.02  1,709,799 
12/16/2024 1.00  1.05  1.00  1.00  1,027,853 
12/13/2024 1.00  1.03  0.99  1.01  2,058,615 
12/12/2024 1.02  1.04  1.00  1.00  2,159,278 
12/11/2024 1.03  1.05  0.99  1.02  1,738,197 
12/10/2024 1.03  1.06  0.99  1.02  1,857,284 
12/09/2024 1.04  1.05  1.00  1.01  1,165,891 
12/06/2024 1.05  1.07  1.00  1.02  1,428,506 
12/05/2024 1.02  1.06  0.97  1.02  6,829,522 
12/04/2024 1.06  1.11  1.01  1.02  6,098,924 
12/03/2024 1.15  1.16  1.07  1.07  2,058,229 
12/02/2024 1.15  1.21  1.15  1.18  1,109,605 
11/29/2024 1.13  1.15  1.10  1.14  962,009 
11/27/2024 1.11  1.15  1.08  1.13  1,675,945 
11/26/2024 1.10  1.12  1.07  1.07  1,366,970 
11/25/2024 1.07  1.12  1.07  1.09  2,480,717 
11/22/2024 1.03  1.11  1.01  1.05  4,632,207 
11/21/2024 1.00  1.04  0.98  1.01  1,455,317 
11/20/2024 1.07  1.07  1.00  1.00  1,486,196 
11/19/2024 1.02  1.04  1.00  1.03  1,502,325 
11/18/2024 1.07  1.09  1.02  1.03  1,390,744 
11/15/2024 1.20  1.20  1.04  1.07  3,766,833 
11/14/2024 1.29  1.30  1.16  1.17  2,363,326 
11/13/2024 1.33  1.37  1.28  1.28  883,402 
11/12/2024 1.37  1.38  1.30  1.31  964,593 
11/11/2024 1.40  1.42  1.36  1.37  1,302,678 
11/08/2024 1.38  1.43  1.36  1.40  1,658,698 
11/07/2024 1.41  1.42  1.33  1.37  1,865,381 
11/06/2024 1.43  1.47  1.36  1.39  2,386,122 
11/05/2024 1.34  1.41  1.34  1.40  2,624,125 
11/04/2024 1.37  1.47  1.26  1.33  5,973,194 
11/01/2024 1.21  1.26  1.21  1.23  842,090 
10/31/2024 1.25  1.25  1.19  1.19  1,187,883 

About Nektar Therapeutics Stock history

Nektar Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Nektar is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Nektar Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Nektar Therapeutics stock prices may prove useful in developing a viable investing in Nektar Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding218.5 M229.4 M
Net Loss-331.4 M-314.8 M

Nektar Therapeutics Quarterly Net Working Capital

218.9 Million

Nektar Therapeutics Stock Technical Analysis

Nektar Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Nektar Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Nektar Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Nektar Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Nektar Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Nektar Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Nektar to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Nektar Stock Analysis

When running Nektar Therapeutics' price analysis, check to measure Nektar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nektar Therapeutics is operating at the current time. Most of Nektar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nektar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nektar Therapeutics' price. Additionally, you may evaluate how the addition of Nektar Therapeutics to your portfolios can decrease your overall portfolio volatility.